Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Whole Genome Sequence of the Rifamycin B-Producing Strain Amycolatopsis mediterranei S699
View through CrossRef
ABSTRACT
Amycolatopsis mediterranei
S699 is an actinomycete that produces an important antibiotic, rifamycin B. Semisynthetic derivatives of rifamycin B are used for the treatment of tuberculosis, leprosy, and AIDS-related mycobacterial infections. Here, we report the complete genome sequence (10.2 Mb) of
A. mediterranei
S699, with 9,575 predicted coding sequences.
Title: Whole Genome Sequence of the Rifamycin B-Producing Strain Amycolatopsis mediterranei S699
Description:
ABSTRACT
Amycolatopsis mediterranei
S699 is an actinomycete that produces an important antibiotic, rifamycin B.
Semisynthetic derivatives of rifamycin B are used for the treatment of tuberculosis, leprosy, and AIDS-related mycobacterial infections.
Here, we report the complete genome sequence (10.
2 Mb) of
A.
mediterranei
S699, with 9,575 predicted coding sequences.
Related Results
Recent trends in rifamycin research
Recent trends in rifamycin research
AbstractRifamycin is a clinically useful macrolide antibiotic produced by the gram positive bacterium. Amycolatopsis mediterranei. This antibiotic is primarily used against Mycobac...
A STUDY ON THE USE OF DIFFERENT MATERIALS COMBINED WITH ALLOGRAFT ON OSSEOINTEGRATION AND BONE REGENERATION OF DENTAL IMPLANTS WITH CORONAL DEFECTS IN A RABBIT MODEL
A STUDY ON THE USE OF DIFFERENT MATERIALS COMBINED WITH ALLOGRAFT ON OSSEOINTEGRATION AND BONE REGENERATION OF DENTAL IMPLANTS WITH CORONAL DEFECTS IN A RABBIT MODEL
Objectives: To assess differential effects of different materials combined with allograft on bone-to-implant contact and newly formed bone formation in dental implants with coronal...
Pharmacokinetics and Safety of Rifamycin SV after Single and Multiple Doses of MMX® Modified Release Tablets in Healthy Male and Female Volunteers
Pharmacokinetics and Safety of Rifamycin SV after Single and Multiple Doses of MMX® Modified Release Tablets in Healthy Male and Female Volunteers
The primary objective of this single- and multiple-dose pharmacokinetic study was the investigation of rifamycin SV’s pharmacokinetic profile in plasma and urine. All the 18 enroll...
Systemic Absorption of Rifamycin SV MMX Administered as Modified-Release Tablets in Healthy Volunteers
Systemic Absorption of Rifamycin SV MMX Administered as Modified-Release Tablets in Healthy Volunteers
ABSTRACT
The new oral 200-mg rifamycin SV MMX modified-release tablets, designed to deliver rifamycin SV directly into the colonic lumen, offer considerable advantages ov...
Genome Mining Reveals Rifamycin Biosynthesis in a Taklamakan Desert Actinomycete
Genome Mining Reveals Rifamycin Biosynthesis in a Taklamakan Desert Actinomycete
Actinomycetes are recognized for producing diverse bioactive natural products, yet most biosynthetic gene clusters (BGCs) remain inactive under laboratory conditions. Rare actinomy...
Farmed oyster mortality follows consistent Vibrio community reorganization
Farmed oyster mortality follows consistent Vibrio community reorganization
ABSTRACT
Mortality events in marine bivalves cause substantial economic losses in aquaculture, yet the microbial dynamics underly...
Farmed oyster mortality follows consistent Vibrio community reorganization
Farmed oyster mortality follows consistent Vibrio community reorganization
Abstract
Mortality events in marine bivalves cause substantial economic losses in aquaculture, yet the microbial dynamics underlying these events...
In Vitro Preliminary Evaluation of a New Rifamycin In Situ Gelling Formulation for Pouchitis Treatment
In Vitro Preliminary Evaluation of a New Rifamycin In Situ Gelling Formulation for Pouchitis Treatment
Pouchitis is one of the most common long-term complications after ileal pouch–anal anastomosis (IPAA) surgery, with a reported incidence rate of up to 50%. Identifying specific bac...